Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin.

Oyoshi MK, Elkhal A, Scott JE, Wurbel MA, Hornick JL, Campbell JJ, Geha RS.

J Clin Invest. 2011 Jun;121(6):2210-20. doi: 10.1172/JCI43586. Epub 2011 May 2.

2.

Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis.

Bartnikas LM, Gurish MF, Burton OT, Leisten S, Janssen E, Oettgen HC, Beaupré J, Lewis CN, Austen KF, Schulte S, Hornick JL, Geha RS, Oyoshi MK.

J Allergy Clin Immunol. 2013 Feb;131(2):451-60.e1-6. doi: 10.1016/j.jaci.2012.11.032.

3.

Induction of skin-pathogenic Th22 cells by epicutaneous allergen exposure.

Glocova I, Brück J, Geisel J, Müller-Hermelink E, Widmaier K, Yazdi AS, Röcken M, Ghoreschi K.

J Dermatol Sci. 2017 Sep;87(3):268-277. doi: 10.1016/j.jdermsci.2017.06.006. Epub 2017 Jun 9.

PMID:
28655472
4.

The prostaglandin D₂ receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge.

He R, Oyoshi MK, Wang JY, Hodge MR, Jin H, Geha RS.

J Allergy Clin Immunol. 2010 Oct;126(4):784-90. doi: 10.1016/j.jaci.2010.07.006. Epub 2010 Aug 14.

6.

Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis.

Tordesillas L, Mondoulet L, Blazquez AB, Benhamou PH, Sampson HA, Berin MC.

J Allergy Clin Immunol. 2017 Jan;139(1):189-201.e4. doi: 10.1016/j.jaci.2016.03.057. Epub 2016 Jun 11.

7.

Differing requirements for CCR4, E-selectin, and α4β1 for the migration of memory CD4 and activated T cells to dermal inflammation.

Gehad A, Al-Banna NA, Vaci M, Issekutz AC, Mohan K, Latta M, Issekutz TB.

J Immunol. 2012 Jul 1;189(1):337-46. doi: 10.4049/jimmunol.1102315. Epub 2012 Jun 4.

8.

TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.

He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS.

Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11875-80. doi: 10.1073/pnas.0801532105. Epub 2008 Aug 18.

9.
10.

Role of regulator of G protein signaling 16 in inflammation-induced T lymphocyte migration and activation.

Lippert E, Yowe DL, Gonzalo JA, Justice JP, Webster JM, Fedyk ER, Hodge M, Miller C, Gutierrez-Ramos JC, Borrego F, Keane-Myers A, Druey KM.

J Immunol. 2003 Aug 1;171(3):1542-55.

11.

IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells.

Galand C, Leyva-Castillo JM, Yoon J, Han A, Lee MS, McKenzie ANJ, Stassen M, Oyoshi MK, Finkelman FD, Geha RS.

J Allergy Clin Immunol. 2016 Nov;138(5):1356-1366. doi: 10.1016/j.jaci.2016.03.056. Epub 2016 Jun 2.

12.

CD1d restricted natural killer T cells are not required for allergic skin inflammation.

Elkhal A, Pichavant M, He R, Scott J, Meyer E, Goya S, Geha RS, Umetsu DT.

J Allergy Clin Immunol. 2006 Dec;118(6):1363-8. Epub 2006 Sep 25.

PMID:
17157667
13.

Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling.

Nakajima S, Igyártó BZ, Honda T, Egawa G, Otsuka A, Hara-Chikuma M, Watanabe N, Ziegler SF, Tomura M, Inaba K, Miyachi Y, Kaplan DH, Kabashima K.

J Allergy Clin Immunol. 2012 Apr;129(4):1048-55.e6. doi: 10.1016/j.jaci.2012.01.063. Epub 2012 Mar 3.

14.

Oral tolerance inhibits atopic dermatitis-like type 2 inflammation in mice by modulating immune microenvironments.

Baek JO, Roh JY, Jung Y.

Allergy. 2017 Mar;72(3):397-406. doi: 10.1111/all.12960. Epub 2016 Jul 22.

PMID:
27325577
15.

IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice.

Jin H, Oyoshi MK, Le Y, Bianchi T, Koduru S, Mathias CB, Kumar L, Le Bras S, Young D, Collins M, Grusby MJ, Wenzel J, Bieber T, Boes M, Silberstein LE, Oettgen HC, Geha RS.

J Clin Invest. 2009 Jan;119(1):47-60. doi: 10.1172/JCI32310. Epub 2008 Dec 15.

16.
17.

Antigen-driven bystander effect accelerates epicutaneous sensitization with a new protein allergen.

Wang LF, Chen JS, Hsu CJ, Liu CY, Yu JS, Miaw SC.

J Biomed Sci. 2009 Mar 6;16:28. doi: 10.1186/1423-0127-16-28.

18.
19.

Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.

Rask C, Holmgren J, Fredriksson M, Lindblad M, Nordström I, Sun JB, Czerkinsky C.

Clin Exp Allergy. 2000 Jul;30(7):1024-32.

PMID:
10848926
20.

Prevention of oral food allergy sensitization via skin application of food allergen in a mouse model.

Li W, Zhang Z, Saxon A, Zhang K.

Allergy. 2012 May;67(5):622-9. doi: 10.1111/j.1398-9995.2012.02798.x. Epub 2012 Feb 17.

PMID:
22339388

Supplemental Content

Support Center